Rohto Pharmaceutical Co.,Ltd. (RPHCF)
USD 20.09
(-24.56%)
USD 20.09
(-24.56%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 270.84 Billion JPY | 14976.62% |
| 2023 | 1.79 Billion JPY | 9.53% |
| 2022 | 1.64 Billion JPY | 0.1% |
| 2021 | 1.63 Billion JPY | -6.1% |
| 2020 | 1.74 Billion JPY | 5.15% |
| 2019 | 1.65 Billion JPY | 2.73% |
| 2018 | 1.61 Billion JPY | 16.43% |
| 2017 | 1.38 Billion JPY | -6.63% |
| 2016 | 1.48 Billion JPY | -99.02% |
| 2015 | 151.99 Billion JPY | 5.49% |
| 2014 | 144.08 Billion JPY | 11.98% |
| 2013 | 128.66 Billion JPY | 6.85% |
| 2012 | 120.42 Billion JPY | 4.48% |
| 2011 | 115.26 Billion JPY | 1.62% |
| 2010 | 113.43 Billion JPY | 2.56% |
| 2009 | 110.6 Billion JPY | 2.21% |
| 2008 | 108.2 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 270.84 Billion JPY | 14976.62% |
| 2024 Q4 | 69.67 Billion JPY | 13314.01% |
| 2024 Q3 | 519.43 Million JPY | 16.38% |
| 2024 Q2 | 446.34 Million JPY | 5.32% |
| 2024 Q1 | 423.79 Million JPY | -9.77% |
| 2023 Q3 | 502.8 Million JPY | 25.39% |
| 2023 Q4 | 469.69 Million JPY | -6.59% |
| 2023 Q1 | 384.8 Million JPY | -15.79% |
| 2023 Q2 | 401 Million JPY | 4.21% |
| 2023 FY | 1.79 Billion JPY | 9.53% |
| 2022 Q3 | 460.38 Million JPY | 5.22% |
| 2022 Q4 | 456.95 Million JPY | -0.75% |
| 2022 FY | 1.64 Billion JPY | 0.1% |
| 2022 Q1 | 381.25 Million JPY | -18.01% |
| 2022 Q2 | 437.55 Million JPY | 14.77% |
| 2021 Q3 | 46.61 Billion JPY | 5.28% |
| 2021 Q2 | 44.28 Billion JPY | 14.21% |
| 2021 FY | 1.63 Billion JPY | -6.1% |
| 2021 Q1 | 38.77 Billion JPY | -23.0% |
| 2021 Q4 | 464.99 Million JPY | -99.0% |
| 2020 FY | 1.74 Billion JPY | 5.15% |
| 2020 Q3 | 47.64 Billion JPY | -1.83% |
| 2020 Q4 | 50.35 Billion JPY | 5.7% |
| 2020 Q1 | 41.85 Billion JPY | -14.57% |
| 2020 Q2 | 48.52 Billion JPY | 15.95% |
| 2019 Q4 | 48.98 Billion JPY | 3.2% |
| 2019 FY | 1.65 Billion JPY | 2.73% |
| 2019 Q3 | 47.46 Billion JPY | 1.9% |
| 2019 Q2 | 46.58 Billion JPY | 14.62% |
| 2019 Q1 | 40.63 Billion JPY | -14.96% |
| 2018 Q2 | 42.54 Billion JPY | 18.51% |
| 2018 Q1 | 35.89 Billion JPY | -16.98% |
| 2018 FY | 1.61 Billion JPY | 16.43% |
| 2018 Q4 | 47.78 Billion JPY | 4.86% |
| 2018 Q3 | 45.57 Billion JPY | 7.12% |
| 2017 Q2 | 38.34 Billion JPY | 16.32% |
| 2017 FY | 1.38 Billion JPY | -6.63% |
| 2017 Q1 | 32.96 Billion JPY | -28.77% |
| 2017 Q4 | 43.23 Billion JPY | 7.97% |
| 2017 Q3 | 40.04 Billion JPY | 4.42% |
| 2016 FY | 1.48 Billion JPY | -99.02% |
| 2016 Q2 | 41.82 Billion JPY | 17.95% |
| 2016 Q4 | 46.28 Billion JPY | 7.86% |
| 2016 Q1 | 35.45 Billion JPY | -20.17% |
| 2016 Q3 | 42.91 Billion JPY | 2.6% |
| 2015 Q4 | 44.41 Billion JPY | 10.78% |
| 2015 Q2 | 37.13 Billion JPY | 22.39% |
| 2015 Q1 | 30.34 Billion JPY | -25.15% |
| 2015 Q3 | 40.09 Billion JPY | 7.96% |
| 2015 FY | 151.99 Billion JPY | 5.49% |
| 2014 Q4 | 40.53 Billion JPY | 5.53% |
| 2014 FY | 144.08 Billion JPY | 11.98% |
| 2014 Q3 | 38.41 Billion JPY | 10.66% |
| 2014 Q2 | 34.71 Billion JPY | 14.12% |
| 2014 Q1 | 30.41 Billion JPY | -15.63% |
| 2013 Q1 | 28.43 Billion JPY | -13.34% |
| 2013 Q2 | 30.37 Billion JPY | 6.8% |
| 2013 Q3 | 33.8 Billion JPY | 11.32% |
| 2013 FY | 128.66 Billion JPY | 6.85% |
| 2013 Q4 | 36.05 Billion JPY | 6.63% |
| 2012 FY | 120.42 Billion JPY | 4.48% |
| 2012 Q1 | 26.04 Billion JPY | -19.01% |
| 2012 Q2 | 29.85 Billion JPY | 14.6% |
| 2012 Q3 | 31.7 Billion JPY | 6.22% |
| 2012 Q4 | 32.81 Billion JPY | 3.49% |
| 2011 Q1 | 24.51 Billion JPY | -20.54% |
| 2011 Q4 | 32.16 Billion JPY | 5.08% |
| 2011 Q3 | 30.61 Billion JPY | 9.42% |
| 2011 Q2 | 27.97 Billion JPY | 14.12% |
| 2011 FY | 115.26 Billion JPY | 1.62% |
| 2010 Q1 | 25.39 Billion JPY | -11.77% |
| 2010 FY | 113.43 Billion JPY | 2.56% |
| 2010 Q4 | 30.85 Billion JPY | 2.67% |
| 2010 Q3 | 30.04 Billion JPY | 10.73% |
| 2010 Q2 | 27.13 Billion JPY | 6.88% |
| 2009 Q2 | 28.71 Billion JPY | 0.0% |
| 2009 FY | 110.6 Billion JPY | 2.21% |
| 2009 Q4 | 28.77 Billion JPY | -4.83% |
| 2009 Q3 | 30.23 Billion JPY | 5.31% |
| 2008 FY | 108.2 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | 117.4 Thousand USD | -230688541.881% |
| Bruush Oral Care Inc. | 2.63 Million USD | -10288445.769% |
| CCA Industries, Inc. | 10.48 Million USD | -2582619.694% |
| DSwiss, Inc. | 1.47 Million USD | -18423499.949% |
| EOS, Inc. | 296.85 Thousand USD | -91237284.286% |
| Greyson International, Inc. | 1684.10 USD | -16082180293.088% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | 120 Thousand USD | -225699900.0% |
| Infusion Brands International, Inc. | 18.18 Million USD | -1489346.509% |
| Mandom Corporation | 483.85 Million USD | -55875.976% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | - USD | -Infinity% |
| Oliveda International, Inc. | 3.86 Million USD | -7013436.872% |
| PacificHealth Laboratories, Inc. | 6.91 Million USD | -3916705.909% |
| Prosperous Future Holdings Limited | 66.24 Million USD | -408737.101% |
| PURE Bioscience, Inc. | 1.96 Million USD | -13797149.109% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | 20 Thousand USD | -1354199900.0% |
| Sentient Brands Holdings Inc. | 150.00 USD | -180559999900.0% |
| Sunset Capital Assets, Inc. | 12.39 Thousand USD | -2185603515.236% |
| The Stephan Co. | 10.58 Million USD | -2559098.715% |
| Turner Valley Oil & Gas, Inc. | 91.00 USD | -297626373526.374% |
| Winning Brands Corporation | 179.21 Thousand USD | -151129859.266% |
| Warpaint London PLC | 114.21 Million USD | -237041.446% |
| Zoono Group Limited | 647.07 Thousand USD | -41855879.823% |
| Zurvita Holdings, Inc. | 7.89 Million USD | -3430950.193% |